Strategic partnerships Perosphere focuses on point-of-care coagulation diagnostics with distribution partnerships overseas (e.g., exclusive Irish distributor M3 Medical) and potential expansion through international distributors, presenting sales opportunities in new markets and hospital networks.

Stroke conference visibility Active engagement in major conferences like the International Stroke Conference with late-breaking posters signals strong clinical relevance and opportunities to connect with hospital systems, stroke centers, and neurology departments seeking rapid coagulation assessment tools.

Clinical validation Recent regulatory milestones such as CE-IVD marking and ongoing clinical demonstrations position the company to pursue hospital procurement cycles, ICU and emergency department pilots, and payer-supported adoption for point-of-care coagulation testing.

Executive leadership New leadership in marketing and external relations alongside advisory board growth indicates a push to scale market awareness, product adoption, and strategic fundraising, creating opportunities for customer-facing outreach and key account engagement.

Mid-market opportunity Revenue in the one-to-tens of millions range with a lean employee base suggests scalable sell-to mid-size hospitals and clinics seeking cost-effective, rapid coagulation diagnostics, with upsell potential to larger networks as adoption expands.